RGS10 and ovarian cancer: Our observation that inhibition of RGS10 and RGS17 expression enhances cell survival in the presence of chemotherapeutics suggests that endogenous RGS10 and RGS17 may suppress constitutive survival signals in ovarian cancer cells.